JP2004526758A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526758A5
JP2004526758A5 JP2002580892A JP2002580892A JP2004526758A5 JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5 JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5
Authority
JP
Japan
Prior art keywords
tsp
composition
angiogenesis inhibitor
cosmetic
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011403 external-priority patent/WO2002083088A1/en
Publication of JP2004526758A publication Critical patent/JP2004526758A/ja
Publication of JP2004526758A5 publication Critical patent/JP2004526758A5/ja
Pending legal-status Critical Current

Links

JP2002580892A 2001-04-13 2002-04-11 紫外線bにより誘導される皮膚損傷の予防法 Pending JP2004526758A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (2)

Publication Number Publication Date
JP2004526758A JP2004526758A (ja) 2004-09-02
JP2004526758A5 true JP2004526758A5 (enExample) 2005-08-18

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580892A Pending JP2004526758A (ja) 2001-04-13 2002-04-11 紫外線bにより誘導される皮膚損傷の予防法

Country Status (8)

Country Link
US (1) US6712617B2 (enExample)
EP (1) EP1377253A4 (enExample)
JP (1) JP2004526758A (enExample)
KR (2) KR20040021598A (enExample)
CN (1) CN100340287C (enExample)
CA (1) CA2446093A1 (enExample)
TW (1) TWI233361B (enExample)
WO (1) WO2002083088A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
EP1559429A4 (en) * 2002-06-25 2009-09-09 Shiseido Co Ltd AGAIN AGING AGING
JP4328293B2 (ja) * 2002-07-31 2009-09-09 メルシャン株式会社 新規生理活性物質
US7576204B2 (en) * 2002-07-31 2009-08-18 Mercian Corporation Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
EP1580278A4 (en) * 2002-11-29 2010-08-25 Mercian Corp METHOD FOR PRODUCING A MAKROLIDE COMPOUND
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US8795315B2 (en) * 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
CA2869452C (en) 2004-10-12 2016-01-19 Tq Delta, Llc Resource sharing in a telecommunications environment
BRPI0613548A2 (pt) * 2005-05-05 2011-01-18 Genencor Int composições de cuidado pessoal e métodos para seu uso
EP2561882A3 (en) * 2005-09-16 2013-04-17 Shiseido Company, Ltd. Novel vascular endothelial growth factor expression inhibitors
EP1984522B1 (en) 2006-01-18 2010-08-11 The General Hospital Corporation Methods of increasing lymphatic function
BRPI0709871B1 (pt) 2006-04-12 2019-10-15 Tq Delta, Llc. Retransmissão de pacote e compartilhamento de memória
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
EP2052723A4 (en) * 2006-08-14 2010-07-28 Eisai R&D Man Co Ltd STABLE LYOPHILIZED PREPARATION
MX2009008068A (es) * 2007-01-29 2009-11-18 Eisai R&D Man Co Ltd Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene.
CA2698812A1 (en) 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
EP4219708A3 (en) 2009-07-17 2023-10-11 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
WO2021133822A1 (en) 2019-12-24 2021-07-01 Juvena Therapeutics,Inc. Regenerative polypeptides and uses thereof
EP4359425A4 (en) 2021-06-21 2025-04-09 Juvena Therapeutics, Inc. REGENERATIVE POLYPEPTIDES AND THEIR USES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
ES2301197T3 (es) * 1997-05-27 2008-06-16 Sembiosys Genetics Inc. Utilizaciones de cuerpos oleosos.
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
CA2368657A1 (en) * 1999-03-31 2000-10-05 The General Hospital Corporation Thrombospondin-2 and uses thereof
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Similar Documents

Publication Publication Date Title
JP2004526758A5 (enExample)
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
Adebajo et al. A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis
ES2310010T3 (es) Composiciones viscosas que contienen dioxido de carbono.
JP2002532432A5 (enExample)
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
DE799037T1 (de) Verfahren und mittel zur behandlung der allergischen rhinitis und anderer erkrankungen mittels descarboethoxyloratadin
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
BRPI0608951A2 (pt) composições e método para o tratamento de acne
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
Stagnone Superficial peeling
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
JP2004508317A (ja) 化粧品組成物および方法
US5753213A (en) Pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts for reducing seborrhea
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2004532268A (ja) 異常な角質性物質を除去するための製剤
JP2013163681A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
AU709422B2 (en) Method for topical treatment of scar tissue and related tissue reaction to trauma
JPH05194140A (ja) 硫黄原子を持つアミノ酸を含有する爪処置用組成物
WO2010074731A2 (en) Nail fungus treatment and composition
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
DE69910600D1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist